These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 7582659

  • 1. The efficacy of lamotrigine on seizure control in 34 children, adolescents and young adults with intellectual and physical disability.
    Buchanan N.
    Seizure; 1995 Sep; 4(3):233-6. PubMed ID: 7582659
    [Abstract] [Full Text] [Related]

  • 2. Lamotrigine: clinical experience in 200 patients with epilepsy with follow-up to four years.
    Buchanan N.
    Seizure; 1996 Sep; 5(3):209-14. PubMed ID: 8902923
    [Abstract] [Full Text] [Related]

  • 3. Lamotrigine: clinical experience in 93 patients with epilepsy.
    Buchanan N.
    Acta Neurol Scand; 1995 Jul; 92(1):28-32. PubMed ID: 7572057
    [Abstract] [Full Text] [Related]

  • 4. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E, Kerls SP, Hammer AE, Vuong A, Messenheimer JA.
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [Abstract] [Full Text] [Related]

  • 5. Long-term safety and efficacy of lamotrigine (Lamictal) in paediatric patients with epilepsy.
    Besag FM, Dulac O, Alving J, Mullens EL.
    Seizure; 1997 Feb; 6(1):51-6. PubMed ID: 9061824
    [Abstract] [Full Text] [Related]

  • 6. Lamotrigine as add-on drug in children and adolescents with refractory epilepsy and mental delay: an open trial.
    Coppola G, Pascotto A.
    Brain Dev; 1997 Sep; 19(6):398-402. PubMed ID: 9339867
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of lamotrigine in institutionalized, developmentally disabled patients with epilepsy: a retrospective evaluation.
    Gidal BE, Walker JK, Lott RS, Shaw R, Speth J, Marty KJ, Rutecki P.
    Seizure; 2000 Mar; 9(2):131-6. PubMed ID: 10845738
    [Abstract] [Full Text] [Related]

  • 8. A randomized open-label study of gabapentin and lamotrigine in adults with learning disability and resistant epilepsy.
    Crawford P, Brown S, Kerr M, Parke Davis Clinical Trials Group.
    Seizure; 2001 Mar; 10(2):107-15. PubMed ID: 11407953
    [Abstract] [Full Text] [Related]

  • 9. Lamotrigine. A review of its use in childhood epilepsy.
    Culy CR, Goa KL.
    Paediatr Drugs; 2000 Mar; 2(4):299-330. PubMed ID: 10946418
    [Abstract] [Full Text] [Related]

  • 10. Adjunctive lamotrigine for refractory epilepsy in adolescents with mental retardation.
    McKee JR, Sunder TR, Vuong A, Hammer AE.
    J Child Neurol; 2006 May; 21(5):372-9. PubMed ID: 16901441
    [Abstract] [Full Text] [Related]

  • 11. Lamotrigine as adjunctive therapy in patients with refractory epilepsy and mental retardation.
    McKee JR, Sunder TR, FineSmith R, Vuong A, Varner JA, Hammer AE, Barrett PS.
    Epilepsy Behav; 2003 Aug; 4(4):386-94. PubMed ID: 12899858
    [Abstract] [Full Text] [Related]

  • 12. Impact of lamotrigine on patients with refractory epilepsy: the Leicester experience.
    Martin PJ, Millac PA.
    Seizure; 1994 Sep; 3(3):209-13. PubMed ID: 8000715
    [Abstract] [Full Text] [Related]

  • 13. Association of lamotrigine and valproate in refractory epilepsies of children and adolescents.
    Grisotto KP, Bruck I, Antoniuk SA, Santos LH.
    Arq Neuropsiquiatr; 2008 Sep; 66(3A):477-81. PubMed ID: 18813703
    [Abstract] [Full Text] [Related]

  • 14. Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits.
    Uvebrant P, Bauzienè R.
    Neuropediatrics; 1994 Dec; 25(6):284-9. PubMed ID: 7770124
    [Abstract] [Full Text] [Related]

  • 15. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
    Jozwiak S, Terczynski A.
    Seizure; 2000 Oct; 9(7):486-92. PubMed ID: 11034873
    [Abstract] [Full Text] [Related]

  • 16. Lamotrigine for the treatment of epilepsy in childhood.
    Besag FM, Wallace SJ, Dulac O, Alving J, Spencer SC, Hosking G.
    J Pediatr; 1995 Dec; 127(6):991-7. PubMed ID: 8523205
    [Abstract] [Full Text] [Related]

  • 17. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy.
    Fitton A, Goa KL.
    Drugs; 1995 Oct; 50(4):691-713. PubMed ID: 8536554
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I, Piñol-Ripoll G, Khurana DS, Hardison HH, Kothare SV, Melvin JJ, Marks HG, Legido A.
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [Abstract] [Full Text] [Related]

  • 20. [Effectiveness and role of lamotrigine in the paradigm shift towards new antiepileptic drugs: a therapeutic strategy proposed after an investigation of a large number of cases at a single hospital].
    Yamamoto T, Yamazoe T, Fujimoto A, Kobayashi R, Yokota T, Okanishi T, Uchiyama G, Ohashi T, Tanaka T, Enoki H.
    Brain Nerve; 2014 Jan; 66(1):59-69. PubMed ID: 24371132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.